Adaptiv Select ETF
ADPV - ETF AI Analysis
Top Page
Adaptiv Select ETF (ADPV)
ADPV, the Adaptiv Select ETF, appears to offer a solid but not top-tier profile, supported by strong holdings like Royalty Pharma and Host Hotels & Resorts, which bring robust profitability, attractive valuations, and growth potential to the fund. APA also adds to the fund’s quality with solid financial performance and effective cash flow management, though weaker names like Avantor and Roivant Sciences, which face revenue and profitability challenges, may drag on the overall rating. A key risk is that several holdings show profitability and valuation pressures, so the fund’s success depends on these companies improving their financial performance over time.
ADPV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 168.83M
- Region
- North America
- Expense Ratio
- 1.00%
- Beta
- 0.60
- Issuer
- Adaptiv
- Inception Date
- Nov 04, 2022
- Dividend Yield
- 0.72%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
ADPV Summary
Adaptiv Select ETF (ADPV) is a U.S. stock fund that focuses on large, established companies across many sectors, including health care, energy, technology, and financials. It doesn’t track a specific index, but instead follows a broad large-cap theme, aiming to blend stability with growth. Well-known holdings include Hewlett Packard Enterprise and Host Hotels & Resorts. Investors might consider ADPV for diversification across many big companies and industries in a single investment. However, it can still go up and down with the overall stock market, and its focus on large U.S. companies means it may miss out on smaller or international growth opportunities.
How much will it cost me?
This ETF has an expense ratio of 1.00%, which means you’ll pay about $10 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed rather than simply tracking an index.
What would affect this ETF?
ADPV could benefit if the U.S. economy stays healthy, supporting large-cap companies in health care, energy, and technology, and if demand for medical innovation, cloud services, and oil and gas remains strong for holdings like Roivant Sciences, Hewlett Packard Enterprise, and Permian Resources. On the downside, higher interest rates, tighter financial regulations, or a slowdown in U.S. growth could hurt real estate and financial holdings such as Host Hotels & Resorts and Central Bancompany, while weaker energy prices or policy changes around health care and fossil fuels could pressure key positions and overall returns.
ADPV Top 10 Holdings
ADPV leans heavily into health care and energy, with names like Roivant Sciences and Centene helping drive the fund as their momentum stays upbeat despite some lingering profitability issues. On the tech side, RingCentral has been a bright spot, rising steadily and giving the portfolio a growth tilt, while Hewlett Packard Enterprise has been more mixed, losing steam in the short term after a strong run earlier in the year. Energy players APA and Permian Resources add muscle, benefiting from firm fundamentals. Overall, it’s a U.S.-centric, large-cap mix with a clear tilt toward defensive health care and cyclical energy.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Viatris | 5.93% | $9.97M | $22.79B | 90.06% | 60Neutral | |
| Roivant Sciences | 5.67% | $9.52M | $28.23B | 91.54% | 58Neutral | |
| Hewlett Packard Enterprise | 5.13% | $8.63M | $60.39B | 120.83% | 68Neutral | |
| APA | 4.54% | $7.62M | $14.98B | 85.53% | 73Outperform | |
| Host Hotels & Resorts | 4.62% | $7.76M | $16.78B | 44.06% | 77Outperform | |
| Central Bancompany | 4.61% | $7.74M | $8.91B | 56.63% | ―― | |
| Centene | 4.16% | $6.99M | $32.47B | 82.42% | 58Neutral | |
| RingCentral | 4.22% | $7.09M | $5.68B | 154.29% | 63Neutral | |
| Avantor | 4.24% | $7.13M | $10.25B | 37.33% | 48Neutral | |
| Royalty Pharma | 4.18% | $7.03M | $38.85B | 75.21% | 79Outperform |
ADPV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ADPV, the sentiment is Negative. The current price of 41.36 is below the 20-day moving average (MA) of 43.22, below the 50-day MA of 43.64, and below the 200-day MA of 44.53, indicating a bearish trend. The MACD of -0.49 indicates Positive momentum. The RSI at 33.63 is Neutral, neither overbought nor oversold. The STOCH value of 14.64 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ADPV.
ADPV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $41.36 | $46.00(11.21% Upside) | $168.83M | 1.00% | 61Neutral | |
| $26.00 | $32.87(26.43% Upside) | $917.36M | 0.35% | 74Outperform | |
| $62.89 | $78.87(25.40% Upside) | $989.12M | 0.18% | 72Outperform | |
| $20.46 | $26.72(30.58% Upside) | $954.31M | 0.75% | 69Neutral | |
| $51.89 | $65.18(25.61% Upside) | $923.90M | 0.35% | 73Outperform | |
| $41.60 | $54.96(32.11% Upside) | $907.51M | 0.55% | 74Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ADPV | Adaptiv Select ETF | 41.36 | 1.95 | 4.94% | |
| INFO | Harbor PanAgora Dynamic Large Cap Core ETF | 26.00 | 2.51 | 10.67% | |
| DSPY | Tema S&P 500 Historical Weight ETF Strategy | 62.89 | 7.15 | 12.83% | |
| FTQI | First Trust Hedged BuyWrite Income ETF | 20.46 | 2.38 | 13.14% | |
| ROCY | JPMorgan Equity Premium Yield ETF | 51.89 | 4.11 | 8.61% | |
| AFLG | First Trust Active Factor Large Cap ETF | 41.60 | 3.79 | 10.01% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
